E-LIB Suche - Ergebnisse für: Delimpasi, Sossana

1

Belantamab mafodotin: an important treatment option for vul..:

Mateos, Maria Victoria ; Weisel, Katja ; Terpos, Evangelos...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

2

Health-related quality of life in relapsed/refractory multi..:

Schjesvold, Fredrik H. ; Ludwig, Heinz ; Delimpasi, Sossana...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

3

Impact of last lenalidomide dose, duration, and IMiD-free i..:

Kastritis, Efstathios ; Roussou, Maria ; Gavriatopoulou, Maria...
Blood Advances. 3 (2019) 23 - p. 4095-4103 , 2019

Link: https://doi.org/10.1182/..

4

Efficacy of isatuximab/pomalidomide/dexamethasone in relaps..:

Harrison, Simon J. ; Richardson, Paul G. ; Alegre, Adrian...
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) 10 - p. e33 , 2019

Link: https://doi.org/10.1016/..

5

Real-world Data on Incidence, Clinical Characteristics and ..:

Katodritou, Eirini ; Kastritis, Efstathios ; Gatt, Moshe...
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) 10 - p. e190-e191 , 2019

Link: https://doi.org/10.1016/..

6

Real-world data on prognosis and outcome of primary plasma ..:

Katodritou, Eirini ; Terpos, Evangelos ; Delimpasi, Sossana...
Blood Cancer Journal. 8 (2018) 3 - p. , 2018

Link: https://doi.org/10.1038/..

7

Phase 2 Study of the All-Oral Combination of Ixazomib Plus ..:

Kumar, Shaji ; Grzasko, Norbert ; Delimpasi, Sossana...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 1 - p. e131 , 2017

Link: https://doi.org/10.1016/..

8

Real-World data for the Treatment of Relapsed/Refractory Mu..:

Katodritou, Eirini ; Delimpasi, Sossana ; Kyrtsonis, Marie Christine...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 1 - p. e130-e131 , 2017

Link: https://doi.org/10.1016/..

9

Real-World Data on Clinical Characteristics, Prognosis and ..:

Katodritou, Eirini ; Terpos, Evangelos ; Delimpasi, Sossana.
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 1 - p. e41 , 2017

Link: https://doi.org/10.1016/..

10

Prior Lenalidomide Resistance and the Impact of IMiD-free I..:

Dimopoulos, Meletios Athanasios ; Roussou, Maria ; Kanellias, Nikolaos...
Clinical Lymphoma Myeloma and Leukemia. 17 (2017) 1 - p. e115-e116 , 2017

Link: https://doi.org/10.1016/..

11

Treatment with bortezomib‐based regimens improves overall r..:

Katodritou, Eirini ; Terpos, Evangelos ; Kelaidi, Charikleia...
American Journal of Hematology. 89 (2013) 2 - p. 145-150 , 2013

Link: https://doi.org/10.1002/..

12

Multiple myeloma in octogenarians: Clinical features and ou..:

Dimopoulos, Meletios A. ; Kastritis, Efstathios ; Delimpasi, Sossana...
European Journal of Haematology. 89 (2012) 1 - p. 10-15 , 2012

Link: https://doi.org/10.1111/..

13

Re‐evaluation of prognostic markers including staging, seru..:

Maltezas, Dimitrios ; Dimopoulos, Meletios A. ; Katodritou, Irene...
Hematological Oncology. 31 (2012) 2 - p. 96-102 , 2012

Link: https://doi.org/10.1002/..

14

High levels of serum angiogenic growth factors in patients ..:

Kastritis, Efstathios ; Roussou, Maria ; Michael, Michalis...
British Journal of Haematology. 150 (2010) 5 - p. 587-591 , 2010

Link: https://doi.org/10.1111/..

15

Validation of the International Prognostic Scoring System (..:

Kastritis, Efstathios ; Kyrtsonis, Marie-Christine ; Hadjiharissi, Evdoxia...
Leukemia Research. 34 (2010) 10 - p. 1340-1343 , 2010

Link: https://doi.org/10.1016/..